0001136261-21-000208.txt : 20210902 0001136261-21-000208.hdr.sgml : 20210902 20210902160835 ACCESSION NUMBER: 0001136261-21-000208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DALESANDRO MARGARET CENTRAL INDEX KEY: 0001208853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 211233319 MAIL ADDRESS: STREET 1: ONCOSEC MEDICAL INCORPORATED STREET 2: 24 NORTH MAIN STREET CITY: PENNINGTON STATE: NJ ZIP: 08534 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEELOS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (646) 293-2100 MAIL ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: APRICUS BIOSCIENCES, INC. DATE OF NAME CHANGE: 20100914 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 4 1 ownership.xml X0306 4 2021-09-01 0 0001017491 SEELOS THERAPEUTICS, INC. SEEL 0001208853 DALESANDRO MARGARET C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 2ND FLOOR NEW YORK NY 10022 1 0 0 0 Stock Option (right to buy) 2.16 2021-09-01 4 A 0 42000 0.00 A 2031-09-01 Common Stock 42000 42000 D One-third of the shares subject to the option shall vest on September 1, 2022, and 1/36th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. /s/ Margaret Dalesandro, Ph.D. 2021-09-02